Presentation during the International Clinical Trials Day, 20 May 2016, Cracow
During the International Clinical Trials Day, which was held on 20 May 2016 in Cracow, Magdalena Wladysiuk, vice-president of HTA Consulting, will give a lecture: HTA – results of analyses and the accessibility to clinical trials
Participation in the discussion panel at the European Economic Congress, 18-20 May 2016, Katowice
On 18–20 May 2016, Katowice will host the eighth edition of the European Economic Congress (EEC). Robet Plisko, president of HTA Consulting, took part in the discussion: Is it attainable to have a healthy return to work?
Poster presentation at the HTAi 2016 Tokyo, Japan
During the HTAi 2016 Annual Meeting in Tokyo, Japan, which will be held from 10th to 14th May 2016, Magdalena Władysiuk, vice president of HTA Consulting, will present a poster: Indirect cost of Rheumatoid Arthritis in Poland - how value is societal perspective.
The report "Rare diseases in Poland" is now available
HTA Consulting invites all interested to read the report, "Rare diseases in Poland. The present situation and perspectives", which was created in collaboration with the Lazarski University.
The report can be found HERE (Polish only).
The report "Analysis of the drugs LABA and LAMA. Accessibility of therapy for the patient"
HTA Consulting finalized its report Analysis of drugs LABA and LAMA. The availability of the treatment for the patient - the perspective of the payer in Poland and in selected EU countries.
Authors: Anna Tytuła, Monika Gumola, Sylwia Krakowska.
Summary of the report can be found HERE (polish version).
Presentation of the report "Rare diseases in Poland"
During the conference "Rare diseases in Poland 2015", held on 12 January 2016 in Warsaw, organized by the University Lazarski, Magdalena Władysiuk, vice-president of HTA Consulting, together with Maria Libura from the Institute of Interdisciplinary Studies, presented a report:
"Rare diseases in Poland"